Effect of Daily Nicotine Patch Application on Mechanical Ventilation Weaning in Smoking Patients
NCT01104896 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 600
Last updated 2010-04-16
Summary
Nicotine patches are frequently used in smoking patients during their stay in the ICU in order to avoid tobacco's weaning symptoms which are likely to interfere with mechanical ventilation weaning.
Until now the effectiveness of this treatment has not been proven. The aim of this study (NICOREA study) is to determine if a difference exists on the duration of mechanical ventilation once patients receive or not a nicotine substitute.
Conditions
- Smoking
- Mechanical Ventilation
- Intensive Care
Interventions
- DRUG
-
Nicotine patch
One or two 15 mg nicotine patch(es) applied from 6am to 10 pm during 21 days
- DRUG
-
One or two placebo patch(es) applied from 6am to 10 pm each day for 21 days
Sponsors & Collaborators
-
Assistance Publique - Hôpitaux de Paris
collaborator OTHER -
University of Paris 5 - Rene Descartes
lead OTHER
Principal Investigators
-
Didier Journois, M.D. Ph.D. · AP-HP, Université René Descartes
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-01-31
- Primary Completion
- 2012-02-29
- Completion
- 2012-02-29
Countries
- France
Study Locations
More Related Trials
-
Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Hospitalized Patients
NCT04608201 ·Status: COMPLETED ·Phase: PHASE3
-
Smoking While on Transdermal Nicotine Replacement Therapy: Effects on Craving and Cessation
NCT00289653 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Electronic Cigarette Withdrawal Syndrome
NCT06066996 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Combination Nicotine Replacement for Alcoholic Smokers
NCT00064844 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Neural Correlates of Personalized Treatment With Transdermal Nicotine Replacement
NCT02439944 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Nicotine Patch for Marijuana Withdrawal
NCT01400243 ·Status: COMPLETED ·Phase: PHASE4
-
Innovative Interventions for Smoking Cessation
NCT01050569 ·Status: COMPLETED ·Phase: PHASE2
-
Concurrent Nicotine Patch / Denicotinized Cigarette Therapy for Smoking Cessation II
NCT00734617 ·Status: COMPLETED ·Phase: PHASE3
-
Nicotine Withdrawal Symptoms and Smoking Relapse
NCT01511614 ·Status: COMPLETED ·Phase: NA
-
Highdose Nicotine Patch Therapy for Smokeless Tobacco Use
NCT00939029 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Cytisine Compared to Combination NRT in Relapsed Smokers
NCT04286295 ·Status: TERMINATED ·Phase: NA
-
Prevention of Nicotine Abstinence in Critically Ill Patients After Major Surgery
NCT03847155 ·Status: COMPLETED ·Phase: NA
-
Effect of Nicotine Pouches on The Underlying Normal Electrocardiogram
NCT07057440 ·Status: COMPLETED ·Phase: NA
-
Combination of Nicotine Replacement Therapy (NRT) and Varenicline to Increase Cessation of Tobacco (CONVICT Study)
NCT01184664 ·Status: COMPLETED ·Phase: PHASE3
-
Nicotine Replacement Therapy and Cardiovascular Disease
NCT02195739 ·Status: UNKNOWN
-
Timing of Smoking Intervention in Alcohol Treatment (Nicotine Patch)
NCT00000444 ·Status: COMPLETED ·Phase: PHASE4
-
Strengthening Instrumental Extinction to Prevent Smoking Relapse (VLNCCue)
NCT02538042 ·Status: COMPLETED ·Phase: NA
-
Effects of Smoking Environments on Craving and Smoking (CameraCue2.0)
NCT02551692 ·Status: COMPLETED ·Phase: NA
-
Medicinal Nicotine for Preventing Stress Induced Craving and Withdrawal Symptoms
NCT01522963 ·Status: COMPLETED ·Phase: NA
-
Nicotine Treatment of Mild Cognitive Impairment (MCI)
NCT00091468 ·Status: UNKNOWN ·Phase: PHASE1
-
Smoking Cessation After Acute Coronary Syndrome
NCT03209622 ·Status: COMPLETED ·Phase: NA
-
Varenicline Versus Transdermal Nicotine Patch for Smoking Cessation in Patients With Coronary Heart Disease
NCT00959972 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Nicotine in Preventing COVID-19 Infection
NCT04583410 ·Status: UNKNOWN ·Phase: PHASE3
-
Impact of Alternative Nicotine-Delivery Products on Combustible Cigarette Use
NCT04084210 ·Status: COMPLETED ·Phase: PHASE2
-
Sympathovagal Balance in Smoking Cessation
NCT01474265 ·Status: COMPLETED ·Phase: PHASE4